Dr. Lal Pathlabs Ltd.

NSE: LALPATHLAB | BSE: 539524 | ISIN: INE600L01024 | Industry: Healthcare Services
| Expensive Rocket
1977.7000 -2.50 (-0.13%)
NSE Nov 18, 2026 11:21 AM
Volume: 60,001
 

1977.70
-0.13%
Emkay
Following the slump in FY23, DLPL has registered revenue/EBITDA/PAT CAGR of 10%/19%/43%, respectively, over the last two years.
Dr. Lal Pathlabs has gained 23.38% in the last 6 Months
More from Dr. Lal Pathlabs Ltd.
Recommended